These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 29174627)

  • 1. Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine.
    Ide S; Ikekubo Y; Mishina M; Hashimoto K; Ikeda K
    J Pharmacol Sci; 2017 Nov; 135(3):138-140. PubMed ID: 29174627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Impairment That Is Induced by (R)-Ketamine Is Abolished in NMDA GluN2D Receptor Subunit Knockout Mice.
    Ide S; Ikekubo Y; Mishina M; Hashimoto K; Ikeda K
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):449-452. PubMed ID: 31135879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice.
    Yamagishi A; Ikekubo Y; Mishina M; Ikeda K; Ide S
    J Pharmacol Sci; 2024 Mar; 154(3):203-208. PubMed ID: 38395521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
    Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Ren Q; Dong C; Fujita Y; Hashimoto K
    Pharmacol Biochem Behav; 2019 Jun; 181():53-59. PubMed ID: 31034852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant Potential of (
    Fukumoto K; Toki H; Iijima M; Hashihayata T; Yamaguchi JI; Hashimoto K; Chaki S
    J Pharmacol Exp Ther; 2017 Apr; 361(1):9-16. PubMed ID: 28115553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.
    Sapkota K; Mao Z; Synowicki P; Lieber D; Liu M; Ikezu T; Gautam V; Monaghan DT
    J Pharmacol Exp Ther; 2016 Mar; 356(3):702-11. PubMed ID: 26675679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
    Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Naito M; Yamaguchi T; Chen L; Kasai A; Seiriki K; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H; Ago Y
    Pharmacol Biochem Behav; 2020 Apr; 191():172876. PubMed ID: 32088360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
    Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
    Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.
    Zhang JC; Li SX; Hashimoto K
    Pharmacol Biochem Behav; 2014 Jan; 116():137-41. PubMed ID: 24316345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the role of the NMDA receptor subunit, GluN2D, in mediating NMDA receptor antagonist-induced behavioral disruptions in male and female mice.
    Vinnakota C; Schroeder A; Du X; Ikeda K; Ide S; Mishina M; Hudson M; Jones NC; Sundram S; Hill RA
    J Neurosci Res; 2024 Jan; 102(1):e25257. PubMed ID: 37814998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase.
    Yamamoto T; Nakayama T; Yamaguchi J; Matsuzawa M; Mishina M; Ikeda K; Yamamoto H
    Neurosci Lett; 2016 Jan; 610():48-53. PubMed ID: 26520463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abolished ketamine effects on the spontaneous excitatory postsynaptic current of medial prefrontal cortex neurons in GluN2D knockout mice.
    Han DH; Hong I; Choi JE; Park P; Baek JY; Park H; Ide S; Mishina M; Ikeda K; Kaang BK
    Mol Brain; 2021 Dec; 14(1):174. PubMed ID: 34876180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling.
    Qu Y; Shan J; Wang S; Chang L; Pu Y; Wang X; Tan Y; Yamamoto M; Hashimoto K
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):439-446. PubMed ID: 33180200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane acts as an antidepressant by suppression of GluN2D-containing NMDA receptors on interneurons.
    Guo F; Zhang B; Shen F; Li Q; Song Y; Li T; Zhang Y; Du W; Li Y; Liu W; Cao H; Zhou X; Zheng Y; Zhu S; Li Y; Liu Z
    Br J Pharmacol; 2024 Sep; 181(18):3483-3502. PubMed ID: 38779864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
    Hashimoto K
    Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
    Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of kynurenine pathway and N-methyl-d-aspartate receptors in the antidepressant-like effect of vilazodone in the tail suspension test in mice.
    de Arruda CM; Doneda DL; de Oliveira VV; da Silva RAL; de Matos YAV; Fernandes IL; Rohden CAH; Viola GG; Rios-Santos F; de Lima E; da Silva Buss Z; Vandresen-Filho S
    Pharmacol Biochem Behav; 2022 Jul; 218():173433. PubMed ID: 35901966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (
    Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction.
    Wilson C; Li S; Hannan AJ; Renoir T
    Neuropharmacology; 2020 May; 168():107998. PubMed ID: 32061666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.